To find new markers for poor recovery of inflammatory bowel disease based on intestinal barrier function and inflammatory stress response markers
Sažetak
Objective: Inflammatory bowel disease (IBD) is one of the common diseases in the department of gastroenterology. We conducted a cross-sectional study on 74 cases of IBD admitted to our hospital from January 2024 to April 2025, with a focus on the changes of serum cytokines in the patients. Subsequently, based on these cytokines, we developed a novel risk model for poor recovery in IBD.
Methods: Based on the estimation of sample size and the screening of inclusion and exclusion criteria, we included 74 IBD patients as the research subjects (January 2024 to April 2025) for a cross-sectional survey. Key indicators were measured, including intestinal barrier markers (I-FABP, DAO, FC), inflammatory cytokines (IL-6, TNF-α, IL-10), Th17/Treg ratio, and stress hormones (Cor, ACTH). Subsequently, Logistic regression analysis was used to establish a risk model for predicting poor recovery of patients.
Results: Patients with IBD have obvious intestinal barrier function impairment: intestinal barrier integrity makers—I-FABP, DAO, and FC—declined by 31.42%, 45.11%, and 37.31%, respectively (P<0.05). In addition, the patient also had a significant inflammatory response, but it decreased after treatment: inflammatory modulation improved, characterized by a rise in IL-10 and declines in IL-6, TNF-α, and the Th17/Treg ratio (P<0.05). Finally, the patient's stress response was significant and relieved after treatment: Cor and ACTH decreased after treatment (P<0.05). After follow-up, 25 patients had poor recovery. Logistic regression analysis showed that ACTH was an independent factor affecting the poor recovery of IBD patients. ROC curve showed that the sensitivity and specificity of ACTH in predicting poor recovery of IBD were 79.59% and 68.00% (AUC=0.710), respectively.
Conclusion: Patients with IBD have obvious intestinal barrier function impairment, and their inflammatory and stress responses are intensified. After the treatment, all these conditions improved. The detection of ACTH can effectively judge the recovery of IBD.
Sva prava zadržana (c) 2026 Renjing Lin, Zongliang Yang
Ovaj rad je pod Creative Commons Autorstvo 4.0 međunarodnom licencom.
The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.